Hybridan Research: Discontinued Research for Physiomics (PYC.L)
Coverage of the equity securities of the following Company has been discontinued. Investors should no longer rely upon our previously published...
91 Views
Primer: Physiomics (PYC LN) - Aug 2026
Physiomics is a niche consultancy leveraging its proprietary Virtual Tumour™ platform to provide Model-Informed Drug Development (MIDD)...
95 Views
Hybridan Small Cap Feast: 28 May 2026
The Kerrs Gold Project hosts a historic NI 43-101 inferred gold resource estimate of 386,467 ounces grading 1.71 g/t Au.
126 Views
Hybridan Research: Physiomics PLC (PYC.L)
To progress business development and support building new capabilities c. £0.45m has been raised at 0.3p a share with a further £0.05m expected...
118 Views
Hybridan Research: Physiomics PLC (PYC.L)
Record revenue of £498k increased by 51.4%, while the total income including £30k of grant income, is £528k compared to £354k which included £25k...
139 Views